The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

T Bald, MF Krummel, MJ Smyth, KC Barry - Nature immunology, 2020 - nature.com
Natural killer (NK) cells belong to the innate immune system and contribute to protecting the
host through killing of infected, foreign, stressed or transformed cells. Additionally, via …

Mechanisms of natural killer cell-mediated cellular cytotoxicity

I Prager, C Watzl - Journal of leukocyte biology, 2019 - academic.oup.com
Cellular cytotoxicity, the ability to kill other cells, is an important effector mechanism of the
immune system to combat viral infections and cancer. Cytotoxic T cells and natural killer …

The natural cytotoxicity receptors in health and disease

AD Barrow, CJ Martin, M Colonna - Frontiers in immunology, 2019 - frontiersin.org
The Natural Cytotoxicity Receptors (NCRs), NKp46, NKp44, and NKp30, were some of the
first human activating Natural Killer (NK) cell receptors involved in the non-MHC-restricted …

Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries

A Montinaro, H Walczak - Cell Death & Differentiation, 2023 - nature.com
Tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) can induce apoptosis
in a wide variety of cancer cells, both in vitro and in vivo, importantly without killing any …

Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy

S Von Karstedt, A Montinaro, H Walczak - Nature Reviews Cancer, 2017 - nature.com
The discovery that the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) can
induce apoptosis of cancer cells without causing toxicity in mice has led to the in-depth study …

[HTML][HTML] Immune evasion in cancer: Mechanistic basis and therapeutic strategies

DS Vinay, EP Ryan, G Pawelec, WH Talib… - Seminars in cancer …, 2015 - Elsevier
Cancer immune evasion is a major stumbling block in designing effective anticancer
therapeutic strategies. Although considerable progress has been made in understanding …

How do cytotoxic lymphocytes kill cancer cells?

L Martínez-Lostao, A Anel, J Pardo - Clinical cancer research, 2015 - AACR
In the past few years, cancer immunotherapy has emerged as a safe and effective
alternative for treatment of cancers that do not respond to classical treatments, including …

NK cell-based immunotherapy for malignant diseases

M Cheng, Y Chen, W Xiao, R Sun, Z Tian - Cellular & molecular …, 2013 - nature.com
Natural killer (NK) cells play critical roles in host immunity against cancer. In response,
cancers develop mechanisms to escape NK cell attack or induce defective NK cells. Current …

All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity

A Ramírez-Labrada, C Pesini, L Santiago… - Frontiers in …, 2022 - frontiersin.org
NK cells are key mediators of immune cell-mediated cytotoxicity toward infected and
transformed cells, being one of the main executors of cell death in the immune system. NK …

The three Es of cancer immunoediting

GP Dunn, LJ Old, RD Schreiber - Annu. Rev. Immunol., 2004 - annualreviews.org
After a century of controversy, the notion that the immune system regulates cancer
development is experiencing a new resurgence. An overwhelming amount of data from …